Annals of Oncology

Editorials:

S. Garattini

New approaches to cancer therapy
Ann Oncol 14: 813-816; doi:10.1093/annonc/mdg261
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Reviews:

G. Parmiani, L. Pilla, C. Castelli, and L. Rivoltini

Vaccination of patients with solid tumours
Ann Oncol 14: 817-824; doi:10.1093/annonc/mdg246
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

F. Mayer, F. Honecker, L. H. J. Looijenga, and C. Bokemeyer

Towards an understanding of the biological basis of response to cisplatin-based chemotherapy in germ-cell tumors
Ann Oncol 14: 825-832; doi:10.1093/annonc/mdg242
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Original articles:

Breast cancer:

M. Martin, A. Villar, A. Sole-Calvo, R. Gonzalez, B. Massuti, J. Lizon, C. Camps, A. Carrato, A. Casado, M. T. Candel, J. Albanell, J. Aranda, B. Munarriz, J. Campbell, and E. Diaz-Rubio

Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM group
Ann Oncol 14: 833-842; doi:10.1093/annonc/mdg260
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

F. Roila, E. Ballatori, L. Patoia, S. Palazzo, A. Veronesi, A. Frassoldati, G. Cetto, S. Cinieri, and A. Goldhirsch

Adjuvant systemic therapies in women with breast cancer: an audit of clinical practice in Italy
Ann Oncol 14: 843-848; doi:10.1093/annonc/mdg256
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

N. Xenidis, I. Vlachonikolis, D. Mavroudis, M. Perraki, A. Stathopoulou, N. Malamos, C. Kouroussis, S. Kakolyris, S. Apostolaki, N. Vardakis, E. Lianidou, and V. Georgoulias

Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer
Ann Oncol 14: 849-855; doi:10.1093/annonc/mdg259
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Gastrointestinal tumors:

D. Fallik, M. Ychou, J. Jacob, P. Colin, J. F. Seitz, J. Baulieux, A. Adenis, J. Y. Douillard, P. Couzigou, R. Mahjoubi, M. Ducreux, M. Mahjoubi, and P. Rougier

Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer
Ann Oncol 14: 856-863; doi:10.1093/annonc/mdg247
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

D. Yip, C. Karapetis, A. H. Strickland, C. Steer, C. Holford, S. Knight, and P. Harper

A dose-escalating study of oral eniluracil/5-fluorouracil plus oxaliplatin in patients with advanced gastrointestinal malignancies
Ann Oncol 14: 864-866; doi:10.1093/annonc/mdg254
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Urogenital tumors:

J. Aparicio, X. García del Muro, P. Maroto, L. Paz-Ares, E. Alba, A. Sáenz, J. Terrasa, A. Barnadas, D. Almenar, J. A. Arranz, M. Sánchez, A. Fernández, J. Sastre, J. Carles, J. Dorca, J. Gumà, A. L. Yuste, and J. R. Germà

Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma
Ann Oncol 14: 867-872; doi:10.1093/annonc/mdg241
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

A. Madani, K. Kemmer, C. Sweeney, C. Corless, T. Ulbright, M. Heinrich, and L. Einhorn

Expression of KIT and epidermal growth factor receptor in chemotherapy refractory non-seminomatous germ-cell tumors
Ann Oncol 14: 873-880; doi:10.1093/annonc/mdg244
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Hematologic malignancies:

A. Wunderlich, M. Kloess, M. Reiser, C. Rudolph, L. Truemper, S. Bittner, H. Schmalenberg, R. Schmits, M. Pfreundschuh, and M. Loeffler

Practicability and acute haematological toxicity of 2- and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin’s lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL)
Ann Oncol 14: 881-893; doi:10.1093/annonc/mdg249
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Lung cancer:

A. Potti, N. Moazzam, K. Ramar, D. S. Hanekom, S. Kargas, and M. Koch

CD117 (c-KIT) overexpression in patients with extensive-stage small-cell lung carcinoma
Ann Oncol 14: 894-897; doi:10.1093/annonc/mdg253
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Gynecologic tumors:

W. S. Sun, J. Fujimoto, and T. Tamaya

Coexpression of growth arrest-specific gene 6 and receptor tyrosine kinases Axl and Sky in human uterine endometrial cancers
Ann Oncol 14: 898-906; doi:10.1093/annonc/mdg257
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Head and neck cancer:

C. Bosetti, C. La Vecchia, R. Talamini, E. Negri, F. Levi, J. Fryzek, J. K. McLaughlin, W. Garavello, and S. Franceschi

Energy, macronutrients and laryngeal cancer risk
Ann Oncol 14: 907-912; doi:10.1093/annonc/mdg251
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Phase I and pharmacokinetics:

J. P. Braybrooke, E. Boven, N. P. Bates, R. Ruijter, N. Dobbs, P. D. Cheverton, H. M. Pinedo, and D. C. Talbot

Phase I and pharmacokinetic study of the topoisomerase I inhibitor, exatecan mesylate (DX-8951f ), using a weekly 30-minute intravenous infusion, in patients with advanced solid malignancies
Ann Oncol 14: 913-921; doi:10.1093/annonc/mdg243
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

K. Nakagawa, T. Tamura, S. Negoro, S. Kudoh, N. Yamamoto, N. Yamamoto, K. Takeda, H. Swaisland, I. Nakatani, M. Hirose, R.-P. Dong, and M. Fukuoka

Phase I pharmacokinetic trial of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (‘Iressa’, ZD1839) in Japanese patients with solid malignant tumors
Ann Oncol 14: 922-930; doi:10.1093/annonc/mdg250
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

C. J. A. Punt, J. Boni, U. Bruntsch, M. Peters, and C. Thielert

Phase I and pharmacokinetic study of CCI-779, a novel cytostatic cell-cycle inhibitor, in combination with 5-fluorouracil and leucovorin in patients with advanced solid tumors
Ann Oncol 14: 931-937; doi:10.1093/annonc/mdg248
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Tumor biology:

A. Fedier, M. Schlamminger, V. A. Schwarz, U. Haller, S. B. Howell, and D. Fink

Loss of atm sensitises p53-deficient cells to topoisomerase poisons and antimetabolites
Ann Oncol 14: 938-945; doi:10.1093/annonc/mdg240
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Epidemiology:

T. Möller, H. Anderson, T. Aareleid, T. Hakulinen, H. Storm, L. Tryggvadottir, I. Corazziari, and E. Mugno

Cancer prevalence in Northern Europe: the EUROPREVAL study
Ann Oncol 14: 946-957; doi:10.1093/annonc/mdg255
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

Letters to the Editor:

M. Magagnoli, G. Masci, C. Carnaghi, P. A. Zucali, L. Castagna, E. Morenghi, and A. Santoro

Minidose warfarin is associated with a high incidence of International Normalized Ratio elevation during chemotherapy with FOLFOX regimen
Ann Oncol 14: 959-960; doi:10.1093/annonc/mdg238
[Extract] [FREE Full Text] [PDF] [Request Permissions]

K. Kagohashi, Y. Funayama, H. Satoh, and K. Sekizawa

Fatal hepatic failure due to gemcitabine and vinorelbine
Ann Oncol 14: 960; doi:10.1093/annonc/mdg239
[Extract] [FREE Full Text] [PDF] [Request Permissions]

K. F. Foo, M. Michael, G. Toner, and J. Zalcberg

A case report of oxaliplatin extravasation
Ann Oncol 14: 961-962; doi:10.1093/annonc/mdg252
[Extract] [FREE Full Text] [PDF] [Request Permissions]

J.-J. De Arriba, C. Nerín, E. García, L. Gómez-Aldaraví, and B. Vila

Severe hemolytic anemia and skin reaction in a patient treated with imatinib
Ann Oncol 14: 962; doi:10.1093/annonc/mdg245
[Extract] [FREE Full Text] [PDF] [Request Permissions]

D. Coradini, S. Veneroni, C. Pellizzaro, and M. G. Daidone

Fluctuation of intratumor biological variables as a function of menstrual timing of surgery for breast cancer in premenopausal patients
Ann Oncol 14: 962-964; doi:10.1093/annonc/mdg258
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Book reviews:

A. Biondi

R. Pinkerton, T. Philip, B. Fervers (eds). Evidence-based Paediatric Oncology
Ann Oncol 14: 965; doi:10.1093/annonc/mdg237
[Extract] [FREE Full Text] [PDF] [Request Permissions]

H. C. Schouten

G.J. Schiller (ed). Chronic Leukemias and Lymphomas: Biology, Pathophysiology and Clinical Management
Ann Oncol 14: 965-966; doi:10.1093/annonc/mdg236
[Extract] [FREE Full Text] [PDF] [Request Permissions]

A. M. L. Oude Lashof and C. J. A. Punt

J. Cassidy, D. Bisset, R.A.J. Spence (eds). Oxford Handbook of Oncology
Ann Oncol 14: 966; doi:10.1093/annonc/mdg235
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Erratum:

J. Boye, T. Elter, and A. Engert

An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab
Ann Oncol 14: 967; doi:10.1093/annonc/mdg263
[Extract] [FREE Full Text] [PDF] [Request Permissions]

Corrigenda:

J. Kerr, J. Engel, A. Schlesinger-Raab, H. Sauer, and D. Hölzel

Communication, quality of life and age: results of a 5-year prospective study in breast cancer patients
Ann Oncol 14: 967; doi:10.1093/annonc/mdg264
[Extract] [FREE Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.